Postgraduate Studentships - Search for funding opportunities.
Postgraduate Studentships - Search for funding opportunities.
London, All England
Looking for a PhD which focusses on improving global health, embeds skills training and combines the expertise of two renowned specialist institutions?
The London Intercollegiate Doctoral Training Partnership (MRC LID) aims to develop a cohort of biomedical and public health scientists with expertise in areas of strategic importance to UK and global medical research. By bringing together two outstanding specialist schools: London School of Hygiene & Tropical Medicine and St George’s, University of London, MRC LID studentship programme provides a high-quality research environment, experienced supervisors and a suite of transferable skills training modules.
MRC LID is funded by the Medical Research Council (MRC), London School of Hygiene & Tropical Medicine (LSHTM) and St George’s, University of London (SGUL).
Learn more about MRC LID
The DTP
Our Doctoral Training Partnership (DTP) offers research projects across four diverse themes in which both institutions have been at the forefront of innovative research and methodological development:
With project topics ranging from malaria to chronic disease and from antimicrobial resistance to vaccine hesitancy, there are over 40 potential projects open for applications as part of the studentship programme.
MRC LID students are registered at both LSHTM and St George’s, University of London, and therefore have access to training and student support at both institutions. MRC LID students benefit from working with internationally recognised researchers who are at the forefront of their disciplines.
Discover all open research projects.
Studentship options
MRC LID offers studentship awards via either 1+4 (Masters + PhD) or +4 (PhD) routes. A limited number of studentships are available each year. For the duration of the award each MRC LID Studentship provides:
All students, regardless of route, will have opportunities to gain new skills to allow them to undertake multidisciplinary or interdisciplinary research, and are required to undertake a required 3-month placement or internship which is not directly related to their PhD research (ideally in Year 2 or 3), as part of this programme.
Learn more about the studentship fees and funding.
Who is eligible to apply?
MRC LID is looking for enthusiastic, motivated, and academically curious applicants from diverse backgrounds with a strong aptitude for research to apply. In selecting successful applicants, the DTP is looking for the potential for applicants to succeed in their chosen research area.
Applicants must hold, or expect to obtain before September 2025, an undergraduate degree (or equivalent qualifications gained outside the UK) in a relevant area.
Those applying for the +4 PhD Studentships should also preferably hold, or expect to obtain, a relevant Masters, or have a combination of relevant qualifications and experience and skills which demonstrates equivalent ability and attainment. This may include a period of employment or internship in a relevant environment.
Some projects have more specific requirements. Applications for the studentship projects are now open and will close on 22 January 2025. Applicants are encouraged to reach out to potential supervisors and begin work on the application process early.
Projects
1. A new approach to understanding the role of tumour microenvironment in anticancer drug resistance
2. Activity and toxicity of AI-Driven Antimicrobial Peptides Against WHO Priority Pathogens
3. Advancing genotype-phenotype correlations with Multiplex Assays of Variant Effect
4. Advancing neglected Plasmodium genomics through cutting-edge sequencing and AI-driven approaches to strengthen malaria control strategies
5. Antimicrobial Resistance (AMR) gene transfer in Methicillin Resistant Staphylococcus aureus (MRSA): mechanisms and dynamics using clinical isolates
6. Antimicrobial resistance: what happens with age and by sex?
7. Assessing the safety of antibiotics for urinary tract infections in pregnancy using routinely collected data
8. Assessing tuberculosis vaccine efficacy using subclinical disease outcomes
9. Bridging the Menstrual Health Gap: Developing and Validating Tools to Assess Menstrual Health in Individuals with Learning Disabilities
10. Characterising infection immunity and pharmacokinetics in HIV-associated pneumocystis pneumonia
11. Combining epidemiological, immunological and climatic data to understand and predict vector-borne epidemics
12. Cost effectiveness and value of implementation of a hypertension management programme in Sub Saharan Africa
13. Cumulative effects of gender inequality on chronic disease and mortality risk across the life course
14. Defining chronic intracellular mechanisms of persistence driving mycobacterial disease
15. Developing a health-specific framework to validate system dynamics and agent-based models used in public health modelling
16. Developing a novel model of mycobacterial infection to study human granulomatous disease
17. Developing Human Papillomavirus (HPV) Vaccines in Stable Nicotiana tabacum: Advancing Plant-Based Solutions for Accessible Immunization
18. Developing novel diagnostics for the management of Dengue fever in a new era of pandemic preparedness
19. Development of a novel and affordable vaccine for worldwide elimination of hepatitis A virus
20. Differential impacts of climate on health among migrant and ethnic minoritised groups in the UK and Brazil
21. Effect of heterogeneity in vaccine hesitancy on the impact of tuberculosis vaccines in South Africa
22. Epidemiological modelling of the impact and mitigation of climate change on tuberculosis
23. Evaluating the burden and risk factors of infectious diseases among newly arrived migrants in the UK, and exploring healthcare models to enhance infectious disease prevention
24. Harnessing Artificial Intelligence to Identify Novel Biomarkers for Ageing
25. High-dimensional approaches for addressing confounding in vaccine research using routinely collected electronic health data
26. Long-term safety of glucocorticoids across treatments modalities
27. Maternal Tuberculosis and Offspring Health: A Nationwide Study in Brazil
28. Modelling the kinetics of immunity to influenza and SARS-CoV-2 in different populations
29. Mpox in Uganda: establishing existing immunity and characterising the immunological response to vaccination in pregnant women
30. Nutrition and cardiovascular risk reduction for youth in Zimbabwe
31. Prediction of dementia from population-wide neuroimaging data using novel brain age techniques
32. Risk prediction models for adverse pregnancy outcomes amongst at risk pregnant women
33. Sex differences in asthma in children and adolescents
34. The epidemiology and dynamics of antifungal resistant Candida acquisition and transmission within ICU settings in high burden Southern African countries
35. The impact of Caesarean section on childhood health
36. The prevalence of antibiotic resistance and antibiotic use in patients with bacterial infections over fifteen years (2010-2025) and interactions with demographic indicators and climate change globally
37. The role of non-genital Chlamydia trachomatis infection in autoimmunity
38. Trained immunity, tissue destruction and novel approaches to treatment in Tuberculosis
39. Understanding drug resistance in key Mycobacterium tuberculosis drug targets using multiplex saturation mutagenesis and AI protein large language models
40. Understanding the Evolution of Antimalarial Drug and Insecticide Resistance: Insights from Genomic and Epigenomic Approaches
41. Understanding the impact of vaccination on the spread of antibiotic resistance using phylogenetics
42. Unravelling novel signalling pathways for inflammation in osteoarthritis development and pain
Do you want to make a positive difference to the health of others? Join a global community of global changemakers and health experts dedicated to imp...
